source
- GSK partners with Chai Discovery to use AI protein-folding models after successful wet-lab testsGSK has entered a collaboration with Chai Discovery, a biotech firm that offers AI‑driven protein folding and design tools. The agreement gives GSK access to Chai's models, which were reported to…
- Pfizer signs $500M deal with Enodia to develop Sec61 protein degradersPfizer has entered a licensing and research collaboration with Enodia Therapeutics, valued at up to $500 million, to discover and develop inhibitors of the Sec61 protein‑translocation channel. The…